West Pharmaceutical Services (WST) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order with introductions of board members, executive team, and independent auditor representative.

• Housekeeping items included voting procedures and technical support information.

• Quorum confirmed with over 50% of outstanding shares present or represented by proxy.

Board and executive committee updates

• Acknowledgement of Thomas W. Hofmann's retirement after 19 years of board service.

• All current director nominees presented for reelection, each to serve a one-year term.

Shareholder proposals

• Four proposals presented: election of directors, advisory vote on executive compensation, ratification of auditor, and a shareholder proposal for an independent board chair.

• Shareholder John Chevedden advocated for separating the roles of CEO and board chair to enhance governance.